Haytaian Peter D's Form 4 filing
Elevance Health, Inc. (ELV) · filed Mar 5, 2024
- Accession no.
- 0001156039-24-000029
- Filed
- Mar 5, 2024
- Trade date
- Mar 1-4, 2024
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 7 non-derivative transactions and 2 derivative transactions. Open-market sales total $10.6M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Haytaian Peter DCIK 0001608538 | Officer (EVP & Pres Carelon & CarelonRx) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 1, 2024 | Common Stock | FTax withholdingDisposed | −4,314 | $499.11 | −$2,153,160.54 | 13,425 | Direct | |
| Mar 1, 2024 | Common Stock | AGrant or awardAcquired | +2,405 | $0.00 | $0 | 15,830 | Direct | |
| Mar 1, 2024 | Common Stock | AGrant or awardAcquired | +9,152 | $0.00 | $0 | 24,982 | Direct | |
| Mar 4, 2024 | Common Stock | MOption exerciseAcquired | +15,000 | $166.97 | +$2,504,550 | 39,982 | Direct | |
| Mar 4, 2024 | Common Stock | SSaleDisposed | −4,206 | $500.18F5 | −$2,103,757.08 | 35,776 | Direct | |
| Mar 4, 2024 | Common Stock | SSaleDisposed | −1,889 | $500.18F5 | −$944,840.02 | 33,887 | Direct | |
| Mar 4, 2024 | Common Stock | SSaleDisposed | −15,000 | $500.18F5 | −$7,502,700 | 18,887 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 1, 2024 | Common Stock | AGrant or awardAcquired | +9,280 | $0.00 | $0 | 9,280 | Direct | |
| Mar 4, 2024 | Common Stock | MOption exerciseDisposed | −15,000 | $0.00 | $0 | 4,908 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F5
This transaction was executed in multiple trades, each at the same price of $500.18. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares at which the transaction was effected.
Referenced by the price of 3 transactions in Table I.